Moreover, given that TOPK interacts with the DNA binding domain (DBD) of tumor suppressor p53 and leads to a decrease in cell cycle regulatory proteins, such as p21, which consequently leads to cancer development and progression [18], PBK/TOPK may be an effective target for antineoplastic kinase inhibitors that induce apoptosis and suppress growth. Here, PBK is linked to cancer.